Permite

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Permite

Quick Facts

Property Description
Active Ingredient Permethrin
Form Topical Cream or Lotion
Pharmacological Class Ectoparasiticide (Scabicide/Pediculicide)
Common Use Treating parasitic skin infestations
Origin Synthetic Pyrethroid

What Type of Medicine is Permite?

Permite is a brand-name medication containing the active ingredient Permethrin, which is formally classified as an ectoparasiticide. This specialized pharmacological class is reserved for agents designed to eliminate parasites that infest the surface of the body, such as mites and lice. Permite is therefore designated as both a scabicide and a pediculicide, categories that reflect its primary application against these external pests.

Permethrin is a foundational therapeutic agent for addressing parasitic infections, utilized for its efficacy in resolving external parasitic problems. Permite's positioning often targets general family use, providing a known and accessible treatment option for conditions resulting from the infestation of mites on the skin.


Permethrin: Synthetic Origin and Topical Form

The core compound, Permethrin, is an effective chemical entity known as a synthetic pyrethroid. Its origin is entirely synthetic, utilizing a structure chemically derived from natural pyrethrins found in chrysanthemum flowers, ensuring consistent activity against arthropods.

Permite is typically supplied as a topical cream or lotion, a pharmaceutical preparation specifically designed for dermal/cutaneous application. The cream base is often favored for providing prolonged skin contact, which is crucial for achieving the targeted elimination of mites. As a single-ingredient product, its therapeutic efficacy relies on the concentrated, localized effect of the synthetic pyrethroid, an action that serves to quickly neutralize the source of the infestation.

Regulatory References

  1. World Health Organization (WHO)
  2. WHO Model List of Essential Medicines (EML)
  3. NIH: Permethrin - StatPearls

What side effects are possible with Permite?

Possible Side Effects and Safety Information

The official safety profile for Permite details known adverse reactions and necessary safety precautions, structured according to classifications used by governmental regulatory authorities like the EMA and FDA. This information outlines the established risks of the medicine.


Frequency-Classified Adverse Reactions

Adverse reactions are documented based on how often they occurred in controlled regulatory studies:

Classification Incidence Rate
Very Common Occurs in 10% or more of patients.
Common Occurs in 1% to less than 10% of patients.
Uncommon Occurs in 0.1% to less than 1% of patients.
Rare Occurs in 0.01% to less than 0.1% of patients.
Not Known Cannot be estimated from available post-marketing data.

These effects are further categorized by System-Organ-Class (SOC), which groups them according to the part of the body affected, such as Gastrointestinal disorders or Nervous system disorders.


Serious Adverse Reactions and Safety Restrictions

Certain adverse events are designated as Serious Adverse Reactions in the official labeling due to their potential clinical significance. The medicine's safety profile also includes formal Contraindications—specific conditions (like known hypersensitivity to the drug) where the medicine must not be used because the risks outweigh any potential benefit.

Population-Specific Safety Notes may be present, which include mandated warnings or necessary monitoring for specific patient groups, such as those with pre-existing hepatic or renal impairment, or statements regarding use during pregnancy or lactation.


This structured regulatory summary defines the known risks and limitations for Permite as determined by authoritative government bodies, informing patients about the medicine's established safety framework.

Overdose and Emergency Response

Overdose and When to Seek Help

The regulatory guidance for Permite (Permethrin) explicitly states that immediate medical attention is required in the event of accidental ingestion of the topical cream. Individuals are instructed to contact a Poison Control Center or physician immediately upon swallowing the product, as determined by national health authorities.


Documented Manifestations and Serious Outcomes

The official overdose profile addresses risks associated with systemic exposure following ingestion and localized reactions from excessive dermal application. The following clinical signs are documented in regulatory prescribing information:

Manifestation Type Documented Symptoms (from regulatory labels)
Systemic Symptoms Nausea, Vomiting, Headache, Dizziness
Local Reactions Increased Irritation, Erythema (redness)
Severe Outcome Convulsion (Seizure)

Management and Specific Considerations

In cases of overdose, management focuses on employing general supportive measures and providing symptomatic treatment for any associated reactions. The regulatory data confirms that no specific antidote for Permethrin is known, anchoring the management approach to supportive care. A specific consideration is noted for accidental ingestion by a child, where medical professionals are advised to consider gastric lavage if the assessment occurs within a two-hour window following the event.

This information strictly reflects the regulatory basis established by government health agencies for the 5% w/w cream formulation.

Therapeutic Uses of Permite

What Permite Treats: Main Uses and Benefits

Permite (Permethrin) is a specialized topical treatment commonly used to address external parasitic problems that affect the skin and hair, providing supportive therapeutic benefits in conditions marked by increased discomfort. The treatment is utilized for its ability to eliminate the parasitic source of infection.


Managing Active Infestations and Discomfort

Permite is relevant for the management of scabies (mite infestation) and various forms of pediculosis (lice infestations, including head, body, and pubic lice). Its role is to help address the infestation by eliminating the parasites, which supports the overall goal of resolving the condition. A major supportive function is the relief of severe pruritus, particularly the intense, nocturnal itching that commonly interferes with daily functioning. By addressing the parasites, the treatment assists in resolving the continuous irritation that triggers the rash and scabies burrows.

“Permite supports the goal of limiting transmission within family and community settings.”

The medication is commonly used across a wide patient spectrum, including adults, children, infants, and geriatric patients, often applied to close contacts to support public health efforts.

Quick Fact: Symptomatic Relief
Symptom Axis Symptoms related to inflammatory or irritative states
Therapeutic Benefit Supports easing overall symptom burden
Usage Context Conditions presenting with systemic or localized discomfort

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Permite? — Official Regulatory Information


Eligibility Scope

Classification Eligibility Status (Regulatory Labeling)
Populations Allowed Adults and children two months of age and older [NIH].
Absolute Contraindication Patients with known hypersensitivity to Permethrin, any synthetic pyrethroid or pyrethrin, or any formulation component [FDA].
Pediatric Restriction Safety and effectiveness have not been established for infants less than two months of age [FDA].
Pregnancy Status Use is conditional. Assigned FDA Pregnancy Category B, requiring use only if clearly needed [FDA].
Lactation Status Use is restricted. It is recommended to consider discontinuing nursing temporarily or withholding the drug [FDA].

Eligibility-Context Constraints

The regulatory profile is structured by hypersensitivity to related compounds (pyrethroids/pyrethrins) as the absolute bar to use, which is a formal contraindication. The key age constraint is the minimum threshold of two months, below which the safety and effectiveness for treatment have not been established by regulators. Use in patients with kidney impairment is generally permitted, as the drug's topical absorption is low and its inactive metabolites are excreted by the kidney.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for Permite (Permethrin 5% topical cream) is defined by a low risk of systemic drug-drug interactions. Official government documentation, including the Summary of Product Characteristics (SmPC) and FDA Prescribing Information, states that no systemic interactions are known with other medicinal products. This is consistent with the active ingredient's minimal percutaneous absorption into the bloodstream.


Official Interaction Statements

Category Documented Interaction Statement
Systemic Drug Interaction None known with oral or systemic medications.
Pharmacodynamic Interference Treatment of eczematous-like reactions with corticosteroids must be withheld prior to Permite application.
Substance-Device Interaction Excipients in the cream reduce the reliability of latex products (e.g., condoms, diaphragms).

The officially documented constraints focus on two main areas. A pharmacodynamic caution requires that topical and systemic corticosteroids be withheld before treatment, as their use may interfere with the intended therapeutic outcome by potentially exacerbating the infestation. The second constraint is an administration-timing rule due to the cream's inactive ingredients. These excipients are documented to reduce the functional reliability of latex products upon concurrent use, imposing a restriction on co-administration with such devices.

Mechanism of Action

Disruption of Neuronal Voltage-Gated Sodium Channels

Permethrin acts primarily through mechanisms that target neuronal signaling processes in arthropods. The drug is a synthetic pyrethroid that acts specifically on voltage-gated sodium channels (VGSCs) in arthropod nerve cell membranes.


Sustained Nerve Membrane Depolarization

The mechanistic effect involves modifying the gating kinetics of the VGSCs. Permethrin binds to the channels and significantly prolongs their open state, preventing normal inactivation and closure. This action initiates a signaling sequence that drives an excessive, sustained influx of positive sodium ions (Na^+) across the membrane.


Physiological Hyper-Excitation and Motor Dysfunction

The sustained ion influx leads to delayed repolarization and continuous excitation (hyperexcitability) of the nerve membrane. This continuous excitation of the membrane results in uncoordinated nerve impulse discharge, leading to motor dysfunction.

Dosage and Administration Information

Permethrin, the active ingredient in Permite, is a topical medication with specific administration guidelines based on the product concentration and treatment area.

Administration Scope and Dosage

Feature 5% Cream (Scabies) 1% Lotion (Head Lice)
Route of Administration Topical, to the skin. Topical, to the hair and scalp.
Standard Dose Sufficient quantity to cover the entire body surface from the neck down. Sufficient quantity to thoroughly saturate the hair and scalp.
Contact Time Leave on the skin for 8 to 14 hours. Leave on the hair for 10 minutes but no longer.
Washing Wash off by showering or bathing after the required contact time. Rinse thoroughly with water.

Procedural and Population Rules

5% Cream for Scabies: The cream must be thoroughly massaged into all skin surfaces. For infants 2 months to 2 years and some elderly patients, the cream must also be applied to the scalp, temples, and forehead. A single application is generally considered curative.

1% Lotion for Head Lice: Hair should be shampooed (without conditioner), rinsed, and towel-dried so it is damp, not wet, before application. The lotion should be applied to completely saturate the hair and scalp, including areas behind the ears and the nape of the neck. If live lice are observed seven days or more after the first treatment, a second application should be given. A fine-toothed comb must be used to remove dead lice and nits after rinsing. This product is generally indicated for children 2 years of age and older.


Effective use requires precise application and timing to ensure the medication remains in contact with the treated area for the necessary duration before removal. Both formulations are for external use only, and contact with the eyes must be avoided, flushing immediately with water if exposure occurs.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Permite (Permethrin)

The research on Permite (Permethrin) consists primarily of controlled clinical studies that examine its use for two main parasitic skin conditions: scabies and pediculosis (lice infestation). This overview describes the type of evidence that exists and the specific outcomes that researchers monitor, while remaining strictly neutral regarding study results.


Evidence for Use in Scabies Infestation

The research base for Permethrin's use in scabies infestation includes Randomized Controlled Trials (RCTs) and analyses of these trials. Research was studied to measure outcomes related to changes in parasitic infestation and symptoms.

Studies were evaluated in populations that included Adults, Children, and Infants over 2 months of age. Research examined key outcomes used to track changes in the infestation, including Parasitological Cure (the confirmed absence of mites or eggs) and Clinical Cure (research endpoints related to skin lesion healing). Studies also monitored patient-reported outcomes describing perceived discomfort, such as the severity and frequency of pruritus (itching).

Research Gaps and Unresolved Questions

A key limitation is the documented prevalence of Permethrin resistance in parasite populations globally; data show patterns related to reduced efficacy in some settings, creating uncertainty. Research is ongoing to address the difficulty in distinguishing between the persistence of symptoms (such as itching) and a true recurrence. Furthermore, long-term effects are not fully established, and long-term outcomes related to sustained clearance and repeated exposure are not well-characterized in the current evidence base.


Evidence in Different Patient Groups

Permethrin was evaluated in a wide range of individuals, but data for certain specialized groups remain insufficient. Studies explored outcomes in both Adults and Children, with evidence existing for use in infants as young as 2 months of age for scabies. However, evidence quality varies across studies, and data for certain specialized groups, particularly those with complex or underlying comorbid conditions, remain insufficient.

Key Studies & References

  1. Permethrin 5% Cream - FDA Approved Labeling (DailyMed)
  2. Permethrin - WHO Model Lists of Essential Medicines (eEML)
  3. Head lice infestations: A clinical update (Pediculosis Resistance)

Frequently Asked Questions (FAQ)

Common questions about Permite (FAQ)

Q: How long does it typically take for Permite to start working?

A: Regulatory documents state that while the medication works to eliminate the parasitic source, symptoms like itching (pruritus) may continue for a period. Clinical observations indicate that for patients whose itching persists for 2 weeks, it has been observed to resolve by 4 weeks following treatment.

Q: Does Permite interact with common over-the-counter medicines?

A: Official safety sources indicate that no systemic drug interactions are known with the active ingredient in Permite. This finding is consistent with the topical nature of the product and its minimal absorption into the bloodstream.

Q: Is Permite considered safe for older adults?

A: Regulatory information indicates that clinical studies did not include enough patients aged 65 and over to fully assess all potential response differences compared to younger adults. However, in reported clinical experience, no specific differences in patient responses between older and younger adults have been identified.

Q: What is the duration of action for Permite?

A: Studies show that only a minimal amount of the active ingredient, around 0.5% of the applied dose, is absorbed through the skin into the bloodstream. This small amount is quickly processed by the liver and eliminated, which indicates a limited and transient systemic presence.

Q: I've heard people use Permite for something else—what are its approved uses?

A: According to the official product information and FDA labeling, the 5% cream formulation is indicated for the treatment of scabies (infestation with Sarcoptes scabiei mites). The 1% formulation is indicated for head lice.

Q: What are the most common reported side effects of Permite?

A: Official safety documents list the most commonly reported side effects at the application site. These include a feeling of mild burning, stinging, tingling, and temporary itching or a rash.

Q: Does Permite stay in the body for a long time?

A: Due to its minimal absorption through the skin, only a small fraction of the medicine enters the bloodstream. This small amount is quickly metabolized in the liver and excreted, which indicates a limited and transient systemic presence.

Q: Does Permite interact with birth control pills?

A: The official summary of product characteristics states that no systemic interactions are known with the active ingredient. This is consistent with the minimal absorption documented for the topical medicine.

Q: How quickly do the symptoms improve after starting Permite?

A: Official information indicates that common symptoms like itching can persist even after the parasitic source is eliminated. In clinical trials, for patients who continued to manifest itching at 2 weeks, the symptom was observed to resolve by 4 weeks.

Q: What is the mechanism of action of Permite, in simple terms?

A: Permite works as an ectoparasiticide, meaning it targets external parasites. In simple terms, the active ingredient works by disrupting the nervous system of the parasites. This disruption leads to sustained nerve activity, causing motor dysfunction in the pest.

Q: Are there any known food or drink interactions with Permite?

A: Official safety information documents no known interactions between the active ingredient in Permite and foods or drinks.

Q: Can Permite cause drowsiness or affect my ability to focus?

A: Regulatory labels classify side effects by System Organ Class. Drowsiness, sleepiness, or issues affecting the ability to focus are not specifically listed as common, uncommon, or rare side effects in the official safety labeling.

Q: Is it normal to feel a mild stinging or burning after using Permite?

A: Yes, official safety information advises patients that a sensation of mild burning and/or stinging is a commonly reported experience. This typically occurs after the cream is applied to the skin.

Q: Is a prescription always required for Permite?

A: The official labeling for the 5% cream formulation indicates that it is a Human Prescription Drug. However, the lower concentration 1% lotion is often available without a prescription.

Q: Can Permite be used if I have asthma or other breathing issues?

A: Official prescribing information includes instructions for healthcare professionals to consider the patient's full medical history, which includes conditions like asthma, before use. There is no absolute contraindication for asthma listed in the labeling.

Q: What does it mean if an official document says Permite is a Category C drug?

A: Permite is assigned FDA Pregnancy Category B. This classification means animal studies showed no evidence of harm to the fetus. However, regulatory standards require this medication to be used during pregnancy only if clearly needed, as there are no adequate studies in pregnant women.

Q: Can Permite cause a rash?

A: Yes, rash is officially listed as a commonly reported side effect in the adverse reactions section of the official safety documents.

Q: Does using Permite mean I need to avoid alcohol?

A: Official safety information documents no known interactions between the active ingredient and alcohol.

Q: What happens if I use too much Permite?

A: Safety documentation highlights that for cases of accidental ingestion, procedures for contacting a poison control center are outlined. This focus on accidental exposure is a primary safety measure listed in regulatory documents.

Q: Is there a generic version of Permite available?

A: The FDA labeling for the 5% cream indicates the product is available as a generic version. This is documented by its designation under an Abbreviated New Drug Application (ANDA) status.

Q: Does Permite have any known effects on fertility?

A: Official regulatory studies in animals have been conducted and revealed no evidence of impaired fertility due to the active ingredient.

Q: Do I need to change my diet while using Permite?

A: Official safety information documents no known interactions between the active ingredient in Permite and foods or drinks.

How should Permite be stored and disposed of?

Storage and Disposal Requirements

Permite (Permethrin Cream 5%) must be stored according to regulatory requirements to ensure product stability. The medicine must be kept at Controlled Room Temperature, defined as a range between 20°C to 25°C (68°F to 77°F). It is critical to store the product out of reach of children to prevent unintended exposure.


Official Storage and Disposal Mandates

Requirement Description
Temperature Range 20 C to 25 C (68 F to 77 F); Excursions allowed up to 30 C.
Safety Protection Keep out of reach of children.
Disposal Protocol Dispose of unused or expired product according to local regulations.

Disposal instructions advise against flushing unused cream down the toilet or pouring it into a drain. Unused medicine should be discarded through a local drug take-back program if one is available.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Permite found in:

A-Z Index: